본문으로 건너뛰기
← 뒤로

Diagnostic Performance of Urinary Biomarker Tests in Detecting Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis.

메타분석 1/5 보강
Urology 📖 저널 OA 7.1% 2021: 0/2 OA 2022: 1/2 OA 2023: 1/6 OA 2024: 1/5 OA 2025: 3/17 OA 2026: 3/50 OA 2021~2026 2026 Vol.210() p. 145-152
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
252 patients.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Our analysis supports a high diagnostic accuracy of the newer urine-based bladder cancer detection tests for evaluating bladder cancer. [PROSPERO REGISTRATION] CRD420251134193.

Siguencia F, Heard J, Smith SM, Pagano I, Furuya H, Wu X, Ahdoot M, Rosser CJ

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.6%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

[OBJECTIVE] To assess the diagnostic estimates of current urine-based diagnostic bladder tests for diagnosing bladder cancer using diagnostic test accuracy (DTA) and network meta-analysis (NMA).

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • Sensitivity 90%
  • Specificity 92%
  • 연구 설계 meta-analysis

이 논문을 인용하기

↓ .bib ↓ .ris
APA Siguencia F, Heard J, et al. (2026). Diagnostic Performance of Urinary Biomarker Tests in Detecting Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis.. Urology, 210, 145-152. https://doi.org/10.1016/j.urology.2026.01.035
MLA Siguencia F, et al.. "Diagnostic Performance of Urinary Biomarker Tests in Detecting Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis.." Urology, vol. 210, 2026, pp. 145-152.
PMID 41651230 ↗

Abstract

[OBJECTIVE] To assess the diagnostic estimates of current urine-based diagnostic bladder tests for diagnosing bladder cancer using diagnostic test accuracy (DTA) and network meta-analysis (NMA).

[METHODS] The search for this systematic review and meta-analysis was conducted on PubMed and Medline for relevant studies published until September 30, 2025. The meta-analysis and network meta-analysis were performed using a random-effect model, to compute the pooled sensitivity and specificity of the markers. The qualitative synthesis included 122 studies comprising 24,252 patients.

[RESULTS] In most studies, there was an unclear risk of bias in the setting of evaluating de novo and recurrent bladder cancer. Novel urine-based assays demonstrated promising diagnostic values with pooled sensitivity upto 90% and specificity upto 92%. The NMA revealed that diagnostic values of the novel urine-based assays were significantly higher than those of cytology for detecting bladder cancer.

[CONCLUSION] Over the past decade, several new urine-based bladder cancer detection assays have become commercially available. Our analysis supports a high diagnostic accuracy of the newer urine-based bladder cancer detection tests for evaluating bladder cancer.

[PROSPERO REGISTRATION] CRD420251134193.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반